Use access key #2 to skip to page content.
$14.94 -0.47 (-3.05%)
7/24/2008 2:13 PM

Insulet Corp (PODD)

CAPS Rating:
**

Dvlp,mftr,mkt insulin infusion system for diabetes

X

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating PODD

Add Stock to Watchlist

What the Community Thinks

Total Members

30 Outperforms
10 Underperforms
 

All-Stars

7 Outperforms
4 Underperforms
 

Wall Street

5 Outperforms
0 Underperforms
 

Members bullish on PODD are also bullish on:

Members bearish on PODD are also bearish on:

Ticker Tags

Diabetic Supplies (3), Small Cap (1922), Micro Cap (4824), IPO in 2007 (239), Medical Device (42), Medical Instruments & Supplies (112)
Suggest a tag

Insulet Corp At A Glance

Current Price: $14.94
Last Trade Time: 7/24/2008 2:13 PM
Open: $15.50
Previous Close: $15.41
Daily Range: $14.84 - $15.59
52-Week Range: $12.35 - $27.85
Volume: 155,765
Market Cap: $424.33M
P/E Ratio: 0.77
Compare Our Special Broker Offers!

Stock Trends

PODD VS S&P 500 (SPY)

PODD 12 month chart vs. S&P

News & Discussion Boards

Other News Headlines for PODD

More Headlines...

Top Bull Pitch

Recs

1

Insulet Corp (PODD)

Avatar BravoBevo (99.91) Submitted: 9/04/07 6:53 PM

Insulet Corporation's claim to fame is its insulin delivery system that allows diabetics to have continuous injection without having to be constantly hooked up to an insulin pump though miles of tubing. The system is likely to become very popular among serious diabetics as it allows the wearer to m...More

Replies: 0 | Reply | Permalink

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 6 :   1 2 Next »

Recs

0

 (PODD)

Avatar matkow (< 20) Submitted: 7/23/08 2:58 PM : Outperform Start Price: $15.64 PODD Score: -2.88

I use there product and it is far superior to all of the other insulin pumps on the market. I have also seen that they are teaming up with several other companies to produce new products such as a combined pump and CGM that may combine the insulin pump and the CGM sensor so you only have to have one thing stuck on your body. That would be a relief for people like me who don't want to stick two things to their bodes.

Also I think that the innovative thinking that made them the first tubeless pump will help guide them to make more improvements to their product.

I think the worst case scenario is they get bought by some larger company like Medtronic or Abbott.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (PODD)

Avatar JonAtkins57 (27.94) Submitted: 6/30/08 1:50 PM : Underperform Start Price: $15.97 PODD Score: 4.88

Market Cap > 100M and < 1B
Gross Margin % < -10
Net Profit Margin % < -10
EPS < -1

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (PODD)

Avatar thedukie (< 20) Submitted: 6/25/08 9:38 AM : Underperform Start Price: $16.27 PODD Score: 3.44

Medtronic will have competitive product in the future, and insulet has production issues and is burning through a lot of cash.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (PODD)

Avatar bulldung (85.52) Submitted: 4/05/08 12:18 AM : Underperform Start Price: $15.75 PODD Score: -3.52

Probably a great idea but total revenue of insulin pump competitors and podd is somewhere near 300m, they have 90+m in cash; their costs of sales,expenses,ie negative cash flow will require them to not only hammer the competition but also convert nonpump diabetics to use the pod I believe they will run out of money before they can do this.As I am a novice and am literally learning from the Foolbook,Investment Guide, this pitch holds as much value as my name

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (PODD)

Avatar BarelyMarginal (26.17) Submitted: 2/07/08 10:41 AM : Outperform Start Price: $18.34 PODD Score: -13.54

Newly on the market medical device maker with very good buzz and decent returns.

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 6 :   1 2 Next »

Wall Street

Results 1 - 5 of 5  

picks per page. CHANGE

Top
Pick		Member NameMember RatingStart
Date		CallTime FrameStart
Price		Stock
Gain		S&P
Gain		ScorePitch
TrackJMP < 20 05/12/08 05/12/08 Outperform NS $19.06-21.24%-9.09%-12.15
TrackHSBC 89.44 10/11/07 10/11/07 Outperform NS $25.20-40.44%-19.56%-20.88
TrackWMBlair 43.94 10/02/07 10/02/07 Outperform NS $22.60-33.58%-17.95%-15.63

Results 1 - 5 of 5  

X

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners